Assessment of Efficacy, Safety, and Prognostic/Predictive Factors of Nintedanib/Docetaxel in Advanced/Recurrent Non–Small Cell Lung Cancer Post-Immunotherapy and Chemotherapy: A Galician Lung Cancer Group Study | Publicación